Paul Tudor Jones II's position in Amedisys is currently worth $16.3 Million. That's 0.20% of their equity portfolio (121st largest holding). The first Amedisys trade was made in Q3 2014. Since then Paul Tudor Jones II bought shares ten more times and sold shares on nine occasions. The stake costed the investor $16.1 Million, netting the investor a gain of 0.8% so far.